Fundraising FoxMagnitude Biosciences
2 known investors
Find your way into Magnitude Biosciences
Sign up to see every warm intro you have to Magnitude Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Magnitude Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Magnitude Biosciences provides a high-powered imaging assay that measures mitochondrial health and age-related morphological changes using C. elegans muscle tissue as a model system. The service helps researchers and pharmaceutical companies assess whether test compounds protect against age-associated mitochondrial degradation.
Founders & leadership
Investors · 2
How we know: NPIF Maven Equity Finance's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- MAGNITUDE BIOSCIENCES LIMITED
- Company number
- 11579884
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 20 Sept 2018
- Registered office
- Netpark Plexus, Thomas Wright Way, Sedgefield, TS21 3FD
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 28 Feb 2026 · next due 30 Nov 2027
- Confirmation statement
- last made up to 27 Aug 2026 · next due 10 Sept 2027
Current officers · 4
- Derek Wilson Mcferran — director, appointed 1 Jul 2025
- Fozia Saleem — director, appointed 3 Oct 2022
- Christopher David Saunter — director, appointed 20 Sept 2018
- Sally Christina Waterman — director, appointed 14 Feb 2022
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Magnitude Biosciences do?
- Magnitude Biosciences provides a high-powered imaging assay that measures mitochondrial health and age-related morphological changes using C. elegans muscle tissue as a model system. The service helps researchers and pharmaceutical companies assess whether test compounds protect against age-associated mitochondrial degradation.
- Who are Magnitude Biosciences's investors?
- Magnitude Biosciences's investors include NPIF Maven Equity Finance, Northstar Ventures.